Crystal and Molecular Structure of Tricarbonyl-[(1R*, 4S*, 4aS*, 9aR*)-1,4-epoxy-2, 3-dimethylidene-1,2,3,4,4a,9,9a,10-octahydroanthracene]iron

The thermal cyclodimerization of 5,6-dimethylidene-7-oxabicyclo[2.2.1]hept-2-ene assisted by Fe₂ (CO)₉ gives the title complex 1 , a precursor for the synthesis of antitumoral anthracyclinones. The crystal structure of 1 has been determined by X-ray diffraction: a = 11.188 (1); c = 26.968 (3) Å; space group tetragonal, P4₁2₁2, Z = 8; R = 0.041; R_W = 0.033. The tricarbonyliron group is in the exo-position and the coordination polyhedron is tetragonal pyramidal. The NMR coupling constants are well-related to the observed dihedral angles between the non-aromatic protons and now give a reliable criterion for assigning the stereochemistry of the metal in d⁸-complexes of 2,3-dimethylidene-7-oxanorbornane derivatives.     

Crystal Structures of rac-Methyl- (3R*, 3aS*, 4R*, 7R*, 7aR*)-7-Acetoxymethyl)-3-benzyl-4,5-dimethyl-1-oxo-3a,4,7,7a-tetrahydroisoindoline-7a-carboxylate

The X-ray structures of the compounds 4 and 2 have been determined by direct methods and refined by least squares techniques. Crystals of C₂₂H₂₇NO₅ and C₂₇H₂₇NO₅ are triclinic, space groups Pī with lattice parameters a = 13.652 (5) Å, b = 10.926 (3) Å, c = 7.755 (2) Å, a = 111.554 (4) Å, β = 85.541 (3) Å, γ = 104.813 (4) Å, and a = 15.394 (4) Å, b = 9.674 (3) Å, c = 8.522 (3) Å, a = 111.04 (4) Å, ß = 93.65 (4) Å, γ = 95.01 (4) Å, respectively.     

(1S*,2S*,4S*,5S*)‐Cyclo­hexa­ne‐1,2,4,5‐tetrol monohydrate

In the title compound, C₆H₁₂O₄·H₂O, 1,4/2,5‐cyclo­hexane­tetrol and water mol­ecules are seen to possess twofold symmetry. All four hydrox­yl groups of the tetrol participate in extensive inter­molecular O—H⋯O hydrogen bonding to form mol­ecular tapes propagating along the a axis. Translationally related tapes along the c axis are held together by four coordinated water mol­ecules.     

Synthesis of (5S*,4aS*,7aS*)-5-hydroxyhexahydro-cyclopenta[c]pyran-3(1H)-one

(5S*,4aS*,7aS*)-5-Hydroxyhexahydrocyclopenta[c]pyran-3(1H)-one, the promising isoprostane building block, was synthesized using intramolecular [3+2] cycloaddition of silyl nitronate generated from 4-benzyloxy-3-nitroocta-2,7-diene on the key step.     

Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3- bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds.

A series of cyclic imides bearing a omega-(4-aryl and 4-heteroaryl-1-piperazinyl)alkyl moieties was synthesized and tested in vivo for anxiolytic activity. The in vitro binding affinities of these compounds were also examined for 5-HT1A receptor sites. Structure-activity relationships within these series are discussed. One of these compounds, (1R*,2S*,-3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3- bicyclo[2.2.1]heptanedicarboximide (1: tandospirone), was found to be equipotent with buspirone in its anxiolytic activity and more anxio-selective than buspirone and diazepam. Tandospirone (1) is currently undergoing clinical evaluation as a selective anxiolytic agent.     

Combinatorial solution-phase synthesis of alkyl (1S*,2S*,3R*,5R*,6R*)-1-alkyl-3-aryl-6-benzoylamino-1-hydroxy-7- oxo-5-phenylhexahydropyrazolo[1,2-a]pyrazole-2-carboxylates

Combinatorial solution-phase cycloadditions of (1Z,4R*,5R*)-4-benzoylamino-5-phenylpyrazolidin-3-on-1-azomethine imines 3 to beta-keto esters 4 afforded a library of 26 bicyclic pyrazolidinones 5 in 6-89% yields and in 14-100% de. All products were isolated in >90% purity according to 1H NMR, and 25 of them were analytically pure. The structures of cycloadducts were confirmed by NMR and X-ray diffraction. Most of the products were isolated as mixtures of the major (1S*,2S*,3R*,5R*,6R*)-epimers 5 and the minor (1R*,2S*,3R*,5R*,6R*)-epimers 6. Epimerization of cycloadducts 5/6 at the anomeric position 1 in solution was confirmed by 1H NMR.